Together, using a tumor-specific MHC class I-restricted TCR, our study depicted the functional and molecular characteristics of cytotoxic CD4+ TCR-Ts at the single-cell transcriptomic level, which revealed the multifaceted cytotoxic pathways for CD4+ TCR-Ts. This evidence concerns the gene CD4 and neoplasm.